Treating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians never know when, where and what resistance might emerge, leaving them one step behind.
IoMT: A Critical Look At The New U.S. Cyber Trust Mark
Shankar Somasundaram, CEO of Asimily The recently proposed U.S. Cyber Trust Mark is a voluntary cybersecurity labeling program operated by the FCC. It will initially
November 7, 2023